Search research articles
Contact Us
Filters
Showing results (461-470 of 540) with videos related to
Page
of 54
Sort By:
Neurobiology of Aging
|
October 5, 2023
Integrated multi-omics analysis of brain aging in female nonhuman primates reveals altered signaling pathways relevant to age-related disorders
Laura A Cox, Sobha Puppala, Jeannie Chan, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2023
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
Michelle E Ramey, Firat Kaya, Allison A Bauman, et al.
American Journal of Human Genetics
|
October 8, 2020
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries
Katherine A Owen, Andrew Price, Hannah Ainsworth, et al.
Frontiers in Immunology
|
June 2, 2020
Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques
Caylin G Winchell, Bibhuti B Mishra, Jia Yao Phuah, et al.
Antimicrobial Agents and Chemotherapy
|
August 11, 2023
Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responses
Nicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.
Nature Medicine
|
September 8, 2015
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux, Laura E Via, Matthew D Zimmerman, et al.
Journal of Medicinal Chemistry
|
January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial Agents
Qiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Frontiers in Oncology
|
December 27, 2021
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
Ashok K Pullikuth, Eric D Routh, Kip D Zimmerman, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for Tuberculosis
Qiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
Journal of Medicinal Chemistry
|
March 4, 2025
Evolution of Small Molecule Inhibitors of <i>Mycobacterium tuberculosis</i> Menaquinone Biosynthesis
Pankaj Sharma, Quan Jiang, Shao-Gang Li, et al.
Page
of 54
Search research articles
Search
Showing results (461-470 of 540) with videos related to
Sort By:
Page
of 54
Neurobiology of Aging
|
October 5, 2023
Integrated multi-omics analysis of brain aging in female nonhuman primates reveals altered signaling pathways relevant to age-related disorders
Laura A Cox, Sobha Puppala, Jeannie Chan, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2023
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
Michelle E Ramey, Firat Kaya, Allison A Bauman, et al.
American Journal of Human Genetics
|
October 8, 2020
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries
Katherine A Owen, Andrew Price, Hannah Ainsworth, et al.
Frontiers in Immunology
|
June 2, 2020
Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques
Caylin G Winchell, Bibhuti B Mishra, Jia Yao Phuah, et al.
Antimicrobial Agents and Chemotherapy
|
August 11, 2023
Lung microenvironments harbor <i>Mycobacterium tuberculosis</i> phenotypes with distinct treatment responses
Nicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, et al.
Nature Medicine
|
September 8, 2015
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux, Laura E Via, Matthew D Zimmerman, et al.
Journal of Medicinal Chemistry
|
January 17, 2025
Metabolically Stable Adenylation Inhibitors of Biotin Protein Ligase as Antibacterial Agents
Qiang Liu, Curtis A Engelhart, Joshua B Wallach, et al.
Frontiers in Oncology
|
December 27, 2021
Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
Ashok K Pullikuth, Eric D Routh, Kip D Zimmerman, et al.
Biorxiv : the Preprint Server for Biology
|
October 3, 2025
Structure-Guided Development of a Potent BioA Inhibitor Validates Biotin Synthesis Inhibition as a Therapeutic Strategy for Tuberculosis
Qiang Liu, Joshua B Wallach, Yahani P Jayasinghe, et al.
Journal of Medicinal Chemistry
|
March 4, 2025
Evolution of Small Molecule Inhibitors of <i>Mycobacterium tuberculosis</i> Menaquinone Biosynthesis
Pankaj Sharma, Quan Jiang, Shao-Gang Li, et al.
Page
of 54